Eastern Bank »

Inhibrx Biosciences shares owned by Eastern Bank

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Eastern Bank from 13F filings

Historical chart of Eastern Bank investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Eastern Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Eastern Bank

Quarter filed Position value Share count Share price at filing
2026-06-30 $474 5 94.80

More positions owned by Eastern Bank

Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
J P Morgan Exchange Traded F Intrnl Res Eqt (JIRE)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Intrm Gov Cr Etf (GVI)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Ishares Msci Emrg Chn (EMXC)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)

View all positions for Eastern Bank

Top funds holding Inhibrx Biosciences

Perceptive Advisors
Viking Global Investors
Morgan Stanley
Sanofi
HighTower Advisors
BlackRock
State Street Corporation
Vanguard Capital Management
Sofinnova Ventures
Capital Research Global Investors
Woodline Partners
Millennium Management
Partner Fund Management
Schonfeld Strategic Advisors
Geode Capital Management

View all funds holding Inhibrx Biosciences